Lou, F., & Fan, X. (2025). Comment on “Efficacy and safety of oxaliplatin-based hyperthermic intraperitoneal chemotherapy with secondary cytoreduction for platinum resistant recurrent ovarian cancer: A single-center retrospective cohort study”. Elsevier.
Chicago Style (17th ed.) CitationLou, Fu, and Xiaohong Fan. Comment on “Efficacy and Safety of Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy with Secondary Cytoreduction for Platinum Resistant Recurrent Ovarian Cancer: A Single-center Retrospective Cohort Study”. Elsevier, 2025.
MLA (9th ed.) CitationLou, Fu, and Xiaohong Fan. Comment on “Efficacy and Safety of Oxaliplatin-based Hyperthermic Intraperitoneal Chemotherapy with Secondary Cytoreduction for Platinum Resistant Recurrent Ovarian Cancer: A Single-center Retrospective Cohort Study”. Elsevier, 2025.